ACADIA PHARMACEUTICALS INC's ticker is and the CUSIP is 4225958. A total of 1 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $6,686,000 | -21.7% | 210,200 | -20.1% | 0.07% | -27.7% |
| Q2 2016 | $8,540,000 | -26.9% | 263,100 | -37.0% | 0.10% | -38.8% |
| Q1 2016 | $11,682,000 | +76.7% | 417,800 | +125.2% | 0.16% | +111.5% |
| Q4 2015 | $6,613,000 | -14.9% | 185,500 | -21.1% | 0.08% | -27.1% |
| Q3 2015 | $7,771,000 | -4.9% | 235,000 | +20.4% | 0.11% | -6.1% |
| Q2 2015 | $8,175,000 | -20.8% | 195,200 | -38.4% | 0.11% | -29.6% |
| Q1 2015 | $10,321,000 | -48.5% | 316,700 | -49.9% | 0.16% | -46.5% |
| Q4 2014 | $20,056,000 | +38.3% | 631,700 | +7.9% | 0.30% | +35.9% |
| Q3 2014 | $14,499,000 | +13.2% | 585,600 | +3.3% | 0.22% | +13.2% |
| Q2 2014 | $12,809,000 | -22.5% | 567,000 | -16.5% | 0.20% | -29.1% |
| Q1 2014 | $16,523,000 | -19.8% | 679,100 | -17.6% | 0.28% | -10.6% |
| Q4 2013 | $20,602,000 | -4.9% | 824,400 | +4.6% | 0.31% | -25.1% |
| Q3 2013 | $21,657,000 | – | 788,400 | – | 0.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 824,400 | $20,602,000 | 0.31% |